Oral administration of lipopolysaccharides for the prevention of various diseases: Benefit and usefulness

Anticancer Research

Volumn 31, Issue 7, 2011, Pages 2431-2436

  Inagawa, Hiroyuki ^a,b,c   Kohchi, Chie ^a,b,c,d   Soma, Gen Ichiro ^a,b,c,d  

^a KAGAWA UNIVERSITY   (Japan)

^b Research and Development Department Macrophi Inc   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Absorption; Endotoxin; Lipopolysaccharide; LPS; Oral administration; Review; Toxicity

Indexed keywords

BINDING PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ALLERGIC DISEASE; CHILL; COLORECTAL CANCER; DENDRITIC CELL; DISEASE ASSOCIATION; DRUG TOLERANCE; ESCHERICHIA COLI; FEVER; GRANULOCYTE; HUMAN; HYPOTENSION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LIFESTYLE; LIVER TOXICITY; NATURAL KILLER CELL; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; SHORT SURVEY; SINGLE DRUG DOSE; VOMITING;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD14; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; LIFE STYLE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MAXIMUM TOLERATED DOSE; MOLECULAR STRUCTURE; PERITONITIS;

EID: 79961187156     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (52)

1. Gioannini TL and Weiss JP: Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. Immunol Res 39: 249-260, 2007. (Pubitemid 47574891)
2. Kawai T and Akira S: The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 11: 373-384, 2010.
3. Yan SR, Qing G, Byers DM, Stadnyk AW, Al-Hertani W and Bortolussi R: Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 72: 1223-1229, 2004. (Pubitemid 38263739)
4. Brown GD: Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6: 33-43, 2006.
5. Otto F, Schmid P, Mackensen A, Wehr U, Seiz A, Braun M, Galanos C, Mertelsmann R and Engelhardt R: Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer. Eur J Cancer 32A: 1712-1718, 1996. (Pubitemid 26306882)
6. Engelhardt R, Mackensen A and Galanos C: Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res 51: 2524-2530, 1991.
7. Engelhardt R, Mackensen A, Galanos C and Andreesen R: Biological response to intravenously administered endotoxin in patients with advanced cancer. J Biol Response Mod 9: 480-491, 1990. (Pubitemid 20366161)
8. Mukaida N, Ishikawa Y, Ikeda N, Fujioka N, Watanabe S, Kuno K and Matsushima K: Novel insight into molecular mechanism of endotoxin shock: biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-kappaB and regulation of cytokine production/action through beta2 integrin in vivo. J Leukoc Biol 59: 145-151, 1996.
9. Inagawa H, Nishizawa T, Tsukioka D, Suda T, Chiba Y, Okutomi T, Morikawa A, Soma G and Mizuno D: Homeostasis as regulated by activated macrophage. II. LPS of plant origin other than wheat flour and their concomitant bacteria. Chem Pharm Bull (Tokyo) 40: 994-997, 1992.
10. Suffredini AF, Hochstein HD and McMahon FG: Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J Infect Dis 179: 1278-1282, 1999. (Pubitemid 29196515)
11. Tschaikowsky K and Brain JD: Effects of liposome-encapsulated dichloromethylene diphosphonate on macrophage function and endotoxin-induced mortality. Biochim Biophys Acta 1222: 323-330, 1994.
12. 14C- lipopolysaccharide. Br J Exp Pathol 66: 303-308, 1985. (Pubitemid 15032567)
13. Oketani K, Inoue T and Murakami M: Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide. Eur J Pharmacol 427: 159-166, 2001. (Pubitemid 32835299)
14. Schryvers AB, Schollaardt T, Woods DE, Williams K and Bryan LE: Efficacy of oral immunization with Pseudomonas aeruginosa lipopolysaccharide. Serodiag Immunother Infect Dis 1: 379-392, 1987.
15. Illyés G, Kovács K, Kocsis B and Baintner K: Failure of oral E. coli O83 lipopolysaccharide to influence intestinal morphology and cell proliferation in rats: short communication. Acta Vet Hung 56: 1-3, 2008. (Pubitemid 351316742)
16. Taniguchi Y, Yoshioka N, Nishizawa T, Inagawa H, Kohchi C and Soma G: Utility and safety of LPS-based fermented flour extract as a macrophage activator. Anticancer Res 29: 859-864, 2009.
17. Murakami M, Tsubata T, Shinkura R, Nisitani S, Okamoto M, Yoshioka H, Usui T, Miyawaki S and Honjo T: Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med 180: 111-121, 1994. (Pubitemid 24181060)
18. Brito RRNe, Cortez BA, Machado-Santelli GM, Xander P, Lorenzo BHD, Oliveira HC, Thies FG, Kioshima ES, Maricato JT, Lopes JD and Mariano M: In vitro and in vivo phagocytic ability of mouse B-1 cells. Immunol Immunogenet Insights 2: 31-39, 2010.
19. Popi AF, Motta FL, Mortara RA, Schenkman S, Lopes JD and Mariano M: Co-ordinated expression of lymphoid and myeloid specific transcription factors during B-1b cell differentiation into mononuclear phagocytes in vitro. Immunology 126: 114-122, 2009.
20. Chen LW, Chang WJ, Chen PH and Hsu CM: Commensal microflora induce host defense and decrease bacterial translocation in bum mice through toll-like receptor 4. J Biomed Sci 17: 48, 2010.
21. Masuda K, Sakai N, Nakamura K, Yoshioka S and Ayabe T: Bactericidal activity of mouse alpha-defensin cryptdin-4 predominantly affects noncommensal bacteria. J Innate Immun 3: 315-326, 2011.
22. Qu XD, Lloyd KC, Walsh JH and Lehrer RI: Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells. Infect Immun 64: 5161-5165, 1996. (Pubitemid 26403975)
23. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S and Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241, 2004.
24. Marquez-Velasco R, Masso F, Hernandez-Pando R, Montano LF, Springall R, Amezcua-Guerra LM and Bojalil R: LPS pretreatment by the oral route protects against sepsis induced by cecal ligation and puncture. Regulation of proinflammatory response and IgM anti-LPS antibody production as associated mechanisms. Inflamm Res 56: 385-390, 2007.
25. Kohchi C, Inagawa H, Nishizawa T, Yamaguchi T, Nagai S and Soma G: Applications of lipopolysaccharide derived from Pantoea agglomerons (IP-PA1) for health care based on macrophage network theory. J Biosci Bioeng 102: 485-496, 2006. (Pubitemid 46162274)
26. Inagawa H, Nishizawa T, Yoshioka N, Taniguchi Y, Kohchi C and Soma G: Preventative and therapeutic potential of lipopolysaccharide derived from edible Gram-negative bacteria to various diseases. Current Drug Therapy 3: 26-32, 2008. (Pubitemid 351223160)
27. Okutomi T, Nishizawa T, Inagawa H, Takano T, Morikawa A, Soma G and Mizuno D: Homeostasis as regulated by activated macrophage. VII. Suppression of serum cholesterol level by LPSw (a lipopolysaccharide from wheat flour) in WHHL (Watanabe heritable hyperlipidemic) rabbit. Chem Pharm Bull (Tokyo) 40: 1268-1270, 1992.
28. Iguchi M, Inagawa H, Nishizawa T, Okutomi T, Morikawa A, Soma G and Mizuno D: Homeostasis as regulated by activated macrophage. V. Suppression of diabetes mellitus in non-obese diabetic mice by LPSw (a lipopolysaccharide from wheat flour). Chem Pharm Bull (Tokyo) 40: 1004-1006, 1992.
29. Suzuki Y, Kobayashi A, Nishizawa T, Inagawa H, Morikawa A, Soma G and Mizuno D: Homeostasis as regulated by activated macrophage. VI. Protective effect of LPSw (a lipopolysaccharide from wheat flour) against acute infection by Toxoplasma gondii in mice. Chem Pharm Bull (Tokyo) 40: 1266-1267, 1992.
30. Takahashi Y, Kondo M, Itami T, Honda T, Inagawa H, Nishizawa T, Soma G and Yokomizo Y: Enhancement of disease resistance against penaeid acute viraemia and induction of virus-inactivating activity in haemolymph of kuruma shrimp, Penaeus japonicus, by oral administration of Pantoea agglomerans lipopolysaccharide (LPS). Fish Shellfish Immunol 10: 555-558, 2000.
31. Inagawa H, Saitoh F, Iguchi M, Nishizawa T, Okutomi T, Morikawa A, Soma G and Mizuno D: Homeostasis as regulated by activated macrophage. III. Protective effect of LPSw (lipopolysaccharide (LPS) of wheat flour) on gastric ulcer in mice as compared with those of other LPS from various sources. Chem Pharm Bull (Tokyo) 40: 998-1000, 1992.
32. Okutomi T, Nishizawa T, Inagawa H, Morikawa A, Takeuchi S, Soma G and Mizuno D: Homeostasis as regulated by activated macrophage. IV. Analgesic effect of LPSw, a lipopolysaccharide of wheat flour. Chem Pharm Bull (Tokyo) 40: 1001-1003, 1992.
33. Okutomi T, Nishizawa T, Inagawa H, Soma G, Minami M, Satoh M and Mizuno D: Inhibition of morphine dependence by a lipopolysaccharide from Pantoea agglomerans. Eur Cytokine Netw 3: 417-420, 1992.
34. Nakata K, Inagawa H and Soma G: Lipopolysaccharide IP-PA1 from Pantoea agglomerans prevents suppression of macrophage function in stress-induced diseases. Anticancer Res 31: 2437-2440, 2011.
35. Benoit R, Rowe S, Watkins SC, Boyle P, Garrett M, Alber S, Wiener J, Rowe MI and Ford HR: Pure endotoxin does not pass across the intestinal epithelium in vitro. Shock 10: 43-48, 1998.
36. Ghoshal S, Witta J, Zhong J, de Villiers W and Eckhardt E: Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50: 90-97, 2009.
37. Dalmo RA, Bøgwald J: Distribution of intravenously and perorally administered Aeromonas salmonicida lipopolysaccharide in Atlantic salmon, Salmo salar L. Fish & Shellfish Immunology 6: 427-441, 1996. (Pubitemid 126171401)
38. Erridge C, Attina T, Spickett CM and Webb DJ: A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86: 1286-1292, 2007. (Pubitemid 350126229)
39. Kucharzik T, Lugering N, Rautenberg K, Lugering A, Schmidt MA, Stoll R and Domschke W: Role of M cells in intestinal barrier function. Ann N Y Acad Sci 915: 171-183, 2000. (Pubitemid 32059378)
40. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, Littman DR and Reinecker HC: CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307: 254-258, 2005. (Pubitemid 40116240)
41. Yoshida M, Claypool SM, Wagner JS, Mizoguchi E, Mizoguchi A, Roopenian DC, Lencer WI and Blumberg RS: Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20: 769-783, 2004. (Pubitemid 38757446)
42. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG and Douek DC: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371, 2006. (Pubitemid 44924494)
43. Koratzanis G, Giamarellos-Bourboulis EJ, Papalambros E and Giamarellou H: Bacterial translocation following intrabdominal surgery. Any influence of antimicrobial prophylaxis? Int J Antimicrob Agents 20: 457-460, 2002.
44. Maes M, Kubera M and Leunis JC: The gut brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29: 117-124, 2008.
45. Mitsuoka T: Significance of dietary modulation of intestinal flora and intestinal environment. Biosci Microflora 19: 15-25, 2000.
46. von Mutius E: Asthma and allergies in rural areas of Europe. Proc Am Thorac Soc 4: 212-216, 2007.
47. von Mutius E: Allergies, infections and the hygiene hypothesis - The epidemiological evidence. Immunobiology 212: 433-439, 2007.
48. Nishizawa T, Inagawa H, Oshima H, Okutomi T, Tsukioka D, Iguchi M, Soma G and Mizuno D: Homeostasis as regulated by activated macrophage. I. Lipopolysaccharide (LPS) from wheat flour: isolation, purification and some biological activities. Chem Pharm Bull (Tokyo) 40: 479-483, 1992.
49. Tanabe Y, Kitahara-Tanabe N, Mizuno D and Soma G: Enhanced production of tumour necrosis factor alpha (TNF-alpha) by its precursor on the cell surface of primed THP-1 cells. Cytokine 6: 337-348, 1994. (Pubitemid 24263877)
50. Tanabe Y, Kohchi C, Kitahara-Tanabe N, Mizuno D and Soma G: Involvement of 26-kDa membrane-bound tumour necrosis factor precursor in bidirectional feedback regulation on 17-kDa tumour necrosis factor production after stimulation by lipopolysaccharide. Cytokine 10: 82-92, 1998. (Pubitemid 28077706)
51. Soma G, Nishizawa T, Inagawa H, Tanabe Y, Noguchi K, Goto S, Takagi K and Mizuno D: Bidirectional feedback regulation on 17 kDa tumor necrosis factor (TNF) production by 26 kDa membrane-bound TNF precursor. J Inflamm 47: 52-60, 1995. (Pubitemid 26376201)
52. Kohchi C, Inagawa H, Hino M, Oda M, Nakata K, Yoshida A, Hori H, Terada H, Makino K, Takiguchi K and Soma G: Utilization of macrophages in anticancer therapy: the macrophage network theory. Anticancer Res 24: 3311-3320, 2004. (Pubitemid 39390946)